Back to DE Deerfield Management Company, L.P.

ALALNYLAM PHARMACEUTICALS INC

Showing 4 of 5 quarters

Position history for DEDeerfield Management Company, L.P.'s holdings in ALNYLAM PHARMACEUTICALS INC

No. Deerfield Management exited its ALNYLAM PHARMACEUTICALS position in Q3 2025. Its Q2 2025 13F listed 110,000,000 shares worth $143.2M. Deerfield Management first reported ALNYLAM PHARMACEUTICALS in Q3 2024 and held it in 4 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$117.3M

Total Shares Change

-110M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%—
0
2025-Q2
Unchanged
110M
0.0%
$143.2M2.6%—
0
2025-Q1
Unchanged
110M
0.0%
$126.9M2.5%—
0
2024-Q4
Increased
110M
+10.0%
$117.3M2.2%—
57

Optional analytics helps us improve. How it’s used